Billable / Specific Code
ICD-10-CM E74.820 is the diagnosis code for SLC13A5 Citrate Transporter Disorder. This code falls under the section "Metabolic disorders" within Chapter 4 — Endocrine, nutritional and metabolic diseases (E00-E89). It is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. Medical coders and healthcare providers use this code to document and classify diagnoses in electronic health records, insurance claims, and clinical databases.
Always refer to the official ICD-10-CM Tabular List for complete coding guidelines. Ensure documentation supports the specificity of the code selected. When in doubt, consult a certified medical coder or the latest CMS guidelines.
Understanding where E74.820 sits in the ICD-10-CM classification helps ensure proper coding:
Yes, E74.820 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
E74.820 is the ICD-10-CM diagnosis code for "SLC13A5 Citrate Transporter Disorder". It is used by healthcare providers to classify and document this condition in medical records and insurance claims.
The parent code of E74.820 is E74.82 ("Disorders of citrate metabolism"). E74.820 provides a more specific classification within this category.
E74.820 is located in Section E70-E88 — "Metabolic disorders" within Chapter 4 of the ICD-10-CM Tabular List.
Use E74.820 when the patients documented diagnosis matches "SLC13A5 Citrate Transporter Disorder" and the clinical documentation supports this level of specificity. Always verify with the latest ICD-10-CM guidelines and payer requirements.
The ICD-10-CM code for SLC13A5 Citrate Transporter Disorder is E74.820.
Yes, E74.820 can be used as a primary diagnosis code since it is billable and specific.
E74.820 is in Chapter 4 of the ICD-10-CM Tabular List.
Yes, E74.820 is a valid ICD-10-CM code for the 2026 fiscal year, subject to official CMS updates.